Hello! You're looking at a policy document report on Overton

We track government policy, guidelines, think tank research, working papers and more to help our customers see the impact and influence of their work. Are you interested in seeing what information we have to offer? Request a free trial to our platform.

If you fund, produce or manage research or work to influence policy, we'd love to talk. Learn more on our homepage.

Serum Lipoprotein Profile Is Associated With Protective Effects of Oral Contraceptive Use on Multiple Sclerosis Severity: A Cross-Sectional Study

Flag for Portugal Government of Portugal on February 6th 2019
Ministry of Health

Topics in this document

Related SDGs

Cites research funded by

1 National Institute of Neurological Disorders and Stroke 1 National Institutes of Health 1 U.S. Department of Health and Human Services 1 NIH (Special project, May 2022) 3 National Multiple Sclerosis Society 1 Department of Defense Multiple Sclerosis Program 1 National Natural Science Foundation of China 1 Nanjing University of Science and Technology 1 Fundamental Research Funds for the Central Universities 1 Ministry of Education of the People's Republic of China 1 Ministry of Finance 1 National Health and Medical Research Council 1 Department of Health and Aged Care, Australian Government 1 China Scholarship Council 2 Fonds Wetenschappelijk Onderzoek 2 Agentschap voor Innovatie door Wetenschap en Technologie 1 Ministry of Health of the Czech Republic 1 Ministerstvo Zdravotnictví Ceské Republiky 1 MRC 1 Merck 1 Bayer HealthCare 1 Teva Pharmaceutical Industries

Citations

This hasn't been cited yet by other documents in the Overton database.
 

Recognized names mentioned in this document

Overton only tracks names from certain institutions. Names must have been cited in at least one policy document and their corresponding affiliation has to be found nearby - you can find more details on the help page.

Zsolt Illes at University of Southern Denmark
On page 1 (or quick view this section)